peeyam
- 08 May 2007 11:30
LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.
Financial details of the deal were not disclosed.
The partners plan to enter into a global licence arrangement for the technology.
Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.
In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.
Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels
As usual, pls do ur own research.
Balerboy
- 17 Jun 2011 21:25
- 1181 of 1204
25% of the max i'm prepared to put into a share so not hurting to bad. I hold over 100,000 shares.,.
dreamcatcher
- 17 Jun 2011 21:28
- 1182 of 1204
Good for you. Link 1179 how many beers have you had. lol or That wine you won
Balerboy
- 17 Jun 2011 21:30
- 1183 of 1204
you in this very deep??
Balerboy
- 17 Jun 2011 21:31
- 1184 of 1204
i meant i buy fruitflow and enjoy it and also think it helps with the blood pressure.,.
dreamcatcher
- 17 Jun 2011 21:35
- 1185 of 1204
No do not have any, will pass now. Just have a few xel, a lot of sou, rrl and xtr. Range will I hope bail the rest out, I hope.
dreamcatcher
- 17 Jun 2011 21:49
- 1186 of 1204
Fruitflow
Balerboy
- 06 Jul 2011 23:04
- 1187 of 1204
Who's taking up the new shares then????
dreamcatcher
- 06 Jul 2011 23:08
- 1188 of 1204
Not another one you have put the mockers on bb
gibby
- 07 Sep 2011 09:45
- 1189 of 1204
seems to be no stopping pxs right now - big resistance at 3p
blanche
- 07 Sep 2011 10:01
- 1190 of 1204
Sssssh!!!
3 monkies
- 31 Jul 2012 17:38
- 1191 of 1204
Down this goes once again on the news!!!!! What happened to the original 8p target then????? Mind you that was suggested in 2007!
dreamcatcher
- 05 Aug 2012 14:39
- 1192 of 1204
MIDAS SHARE TIPS: Sports nutrition firm Provexis helped power our rowers to gold and now its shares could win bigBy Joanne Hart
PUBLISHED: 22:06, 4 August 2012 | UPDATED: 13:46, 5 August 2012
Comments (1) Share
..
Provexis is a sports nutrition and health food business with a difference. Using scientifically proven formulas to boost performance and improve health, the company’s products are used by GB Rowing, several Tour de France teams and hosts of other athletes – Olympians and enthusiasts alike.
The shares are just 1.5p but the company has recently been restructured and its performance should pick up significantly over the next 12 months and beyond.
Professional and amateur athletes spend nearly £20billion a year worldwide on sports nutrition, ranging from Lucozade to hydrating gels and energy tablets. In Britain alone, the market is worth £300million annually.
Golden girls: Heather Stanning and Helen Glover use Provexis products
For serious competitors, nutrition is an integral part of their preparation. In the Tour de France, cyclists consume about 7,000 calories a day and other endurance sports, such as rowing and marathon running, take similar tolls on the body. Trying to maintain energy levels in the face of such pressure is a big challenge.
Provexis takes a rigorous approach, using only natural ingredients to create powders, gels and drinks that are packed with proteins and carbohydrates to help athletes carry on for longer and recover faster.
The firm works with scientists and its products are held in high regard by the sporting community. Its relationship with the British rowing team, for which it is the official sports nutrition partner, dates back several years, and it works with leading cyclists, including Olympic road race winners Alexandre Vinokourov and Marianne Vos.
Provexis is not just about sporting nutrition, however. In fact, the company moved into this sector only last year, when chief executive Stephen Moon bought family business Science in Sport. Since that acquisition in June 2011, Moon has worked hard to improve the availability of Science in Sport’s products and boost productivity.
Provexis was spun out of Aberdeen University, where scientists were trying to understand why people in Mediterranean countries suffer fewer heart attacks than those in other nations.
After years of research, they concluded that the gel around tomato pips has special properties that help to prevent blood clots. The group developed a special extract, Fruitflow, which works in much the same way as aspirin but is entirely natural and has no harmful side-effects.
Developing the product was time-consuming and expensive so Provexis entered into a joint venture with Dutch conglomerate DSM, whose food division turns over £1.5billion a year. Selected sales of Fruitflow in syrup form have started but a tablet version is expected to go on sale soon. This has enormous potential.
More than 50million Americans take aspirin every day and consumption in Britain is extensive, too. If even a fraction of these move to natural, food-based pills instead, Provexis could see sales and profits soar.
The company reported full-year results last week, which showed a surge in turnover from £50,000 to £3.5million in the year to March 31. There was an underlying loss of £2.2million, reflecting investment in Fruitflow and restructuring costs as Moon took steps to streamline the business. But the group should move into profit over the next year or so.
Midas verdict: Provexis is a small company in a fast-growing sector. Moon, formerly at Lucozade-maker GlaxoSmithKline, is down to earth and determined. The past few years have been focused on development. The next few years are all set to be about sales and profits. Provexis should prove to be a winner. Buy.
Read more: http://www.thisismoney.co.uk/money/investing/article-2183743/MIDAS-SHARE-TIPS-Olympic-sports-nutrition-firm-Provexis-marks.html#ixzz22g8mkSlv
3 monkies
- 05 Aug 2012 16:55
- 1193 of 1204
A nice bit of reading dc - I paid 5.082 so quite a way to go for me, but may be next year. Hopefully!!
dreamcatcher
- 05 Aug 2012 17:45
- 1194 of 1204
Not one I have 3m , lets hope it comes right for you.
3 monkies
- 05 Aug 2012 18:07
- 1195 of 1204
Cheers dc - something needs to come right eventually, sooner than later I hope for all of us one way or another.
dreamcatcher
- 05 Aug 2012 18:10
- 1196 of 1204
Agree 3m, Ive gone diverse. (having a variety, assorted share range) Staying clear of oil shares, not been kind to me.
3 monkies
- 06 Aug 2012 09:46
- 1197 of 1204
This is motoring this morning!!
kimoldfield
- 08 Aug 2012 13:16
- 1198 of 1204
Is PXS stepping on GSK's toes now? I'm surprised a takeover rumour hasn't been started. Let's do it! :o)
gibby
- 05 Nov 2013 10:42
- 1199 of 1204
blimey a blast from the past - pxs is actually on the move lols
Balerboy
- 05 Nov 2013 20:32
- 1200 of 1204
one of my big mistakes, did you know fruitflow isn't on the shelves anymore not even on amazon or holland and barratt. I liked it but it's fizzled out..... bit like the comp.,.